Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

T.I. Verhoef; W.K. Redekop; S  Langenskiold; F. Kamali; M. Wadelius; G. Burnside; A.H. Maitland-van der Zee; Dyfrig Hughes; Munir Pirmohamed

doi:10.1038/tpj.2016.41

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

T.I. Verhoef
, W.K. Redekop
, S Langenskiold
, F. Kamali
, M. Wadelius
, G. Burnside
, A.H. Maitland-van der Zee
, Dyfrig Hughes
, Munir Pirmohamed

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	478–484
Journal	The Pharmacogenomics Journal
Volume	16
Early online date	7 Jun 2016
DOIs	https://doi.org/10.1038/tpj.2016.41
Publication status	Published - Oct 2016

Access to Document

10.1038/tpj.2016.41

Cite this

@article{42bd974c31514ba3bf37526a340bb1ab,

title = "Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden",

author = "T.I. Verhoef and W.K. Redekop and S Langenskiold and F. Kamali and M. Wadelius and G. Burnside and \{Maitland-van der Zee\}, A.H. and Dyfrig Hughes and Munir Pirmohamed",

year = "2016",

month = oct,

doi = "10.1038/tpj.2016.41",

language = "English",

volume = "16",

pages = "478–484",

journal = "The Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden

AU - Verhoef, T.I.

AU - Redekop, W.K.

AU - Langenskiold, S

AU - Kamali, F.

AU - Wadelius, M.

AU - Burnside, G.

AU - Maitland-van der Zee, A.H.

AU - Hughes, Dyfrig

AU - Pirmohamed, Munir

PY - 2016/10

Y1 - 2016/10

U2 - 10.1038/tpj.2016.41

DO - 10.1038/tpj.2016.41

M3 - Article

SN - 1470-269X

VL - 16

SP - 478

EP - 484

JO - The Pharmacogenomics Journal

JF - The Pharmacogenomics Journal

ER -